Výsledky vyhledávání - "V. J. J. Bom"

Pharmacokinetics of Human Recombinant Tissue-Type Plasminogen Activator, Administered Intra-Abdominally, in a Rat Peritonitis Model

Autor: J.S. de Graaf, V. J. J. Bom, J van der Meer, H. van Goor, W van der Schaaf, Willem Sluiter, R.P. Bleichrodt, S Geerards

Publikováno v: European Surgical Research, 28, 287-294
European Surgical Research, 28, pp. 287-294
European surgical research, 28(4), 287-294. KARGER

Human recombinant tissue-type plasminogen activator (rtPA), administered intraperitoneally, may promote intra-abdominal fibrinolysis in peritonitis, thereby preventing adhesion and abscess formation. The pharmacokinetics of a single intraperitoneal d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140bb4e851535362429ec2706f0ec5ff
https://doi.org/10.1159/000129468

Zobrazit plný text záznamu

Plasma Levels of Protein S, Protein C, and Factor X: Effects of Sex, Hormonal State and Age

Autor: P. M. Pelsma, Cts Sibinga, J van der Meer, PJ de Kam, C. M. A. Henkens, W van der Schaaf, V. J. J. Bom

Publikováno v: Thrombosis and Haemostasis. 74:1271-1275

SummaryWe measured total and free protein S (PS), protein C (PC) and factor X (FX) in 393 healthy blood donors to assess differences in relation to sex, hormonal state and age. All measured proteins were lower in women as compared to men, as were lev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4d5742058673b882e57543eeb1907e70
https://doi.org/10.1055/s-0038-1649925

Zobrazit plný text záznamu

In-vivo evaluation of the HIA-VAD

Autor: V. J. J. Bom, A.G. Hensens, G.J. Verkerke, Gerhard Rakhorst, C.P.E. Magielse, H. Reul, J. van der Meer, R. Eilers, Paul K. Blanksma, J. M. Elstrodt

Publikováno v: Thoracic and cardiovascular surgeon, 42(3), 136-140

Helmholtz Ventricular Assist Devices (VAD) are pneumatically driven polyurethane membrane pumps with various volumes. The pumps are placed paracorporeally and connected with commercially available cannulas between the left atrium and aorta (left vent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97d5c18a3dedde11ffc7836f61d0f6df
https://doi.org/10.1055/s-2007-1016475

Zobrazit plný text záznamu

Severe bleeding caused by an inhibitor to coagulation factor V

Autor: W. M. Smid, J. H. Nijland, J. T. M. De Wolf, V. J. J. Bom, J van der Meer

Publikováno v: Blood Coagulation & Fibrinolysis. 5:133-138

A 67-year-old man with a severe bleeding due to a high level of factor V inhibitor (maximum level of 350 Bethesda units) is described. Coagulation abnormalities improved initially during treatment with prednisolone in combination with cyclophosphamid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c0b748dc7af21c39ac55d43a1b3f0a6
https://doi.org/10.1097/00001721-199402000-00015

Zobrazit plný text záznamu

Rapid enzyme immunoassay of anti-streptokinase antibodies in human plasma

Autor: Johan Brügemann, J Vandermeer, V. J. J. Bom, W van der Schaaf, Rt Vanwijk

Publikováno v: Clinica Chimica Acta. 218:121-129

A simple enzyme immunoassay for determination of anti-streptokinase antibodies (aSKa) in plasma is described. Commercially available reagents have been used for the assay, which is calibrated with a reference preparation of aSKa containing 100 AU/ml.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce9de541675a7dbe87f740eb874a146
https://doi.org/10.1016/0009-8981(93)90176-5

Zobrazit plný text záznamu

Hemolysis in fresh human blood with a new hemoperfusion pump to prevent myocardial ischemia during coronary angioplasty

Autor: Ki Lie, Ed Demuinck, Jg Meeder, Gj Verkerke, Cpe Magielse, V. J. J. Bom

Publikováno v: Technology and Health Care. 1:165-170

A new, 5 ml, piston type hemoperfusion pump, designed to prevent myocardial ischemia during coronary angioplasty, was evaluated in vitro at different flow rates. The driving pressures necessary to achieve the different flow rates and biochemical indi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3febfd2786eb77995c0f8553ab308a40
https://doi.org/10.3233/thc-1993-1207

Zobrazit plný text záznamu

Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans

Autor: Bpc Hazenberg, Hg Devrieshospers, J Vandermeer, J Vaningen, V. J. J. Bom, Asm Dofferhoff, J Weits, Pom Mulder

Publikováno v: Critical Care Medicine. 20:185-192

Objective: To study the patterns of plasma concentrations of endotoxin, tumor necrosis factor-alpha (TNF), interleukin-6 (IL-6), plasminogen activator inhibitor-1, C-reactive protein, and serum amyloid A during the treatment of human sepsis. Design:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56504bfb2aeb272d9657f3ff5d993068
https://doi.org/10.1097/00003246-199202000-00007

Zobrazit plný text záznamu

Effects of Different Types and Combinations of Antimicrobial Agents on Endotoxin Release from Gram-negative Bacteria: An In-Vitro and In-Vivo Study

Autor: Pom Mulder, J Weits, V. J. J. Bom, Asm Dofferhoff, Hg Devrieshospers, Jh Nijland

Publikováno v: Scandinavian Journal of Infectious Diseases. 23:745-754

Total and free endotoxin release in time from cultures of Escherichia coli by different antibiotics was studied in vitro for 4 h in relation to the antibiotic effect on viable counts and morphological features of the test cultures. The most rapid fal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8c903eb2c22a69616155daf399fa96d
https://doi.org/10.3109/00365549109024303

Zobrazit plný text záznamu

Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations

Autor: Hans L. Hillege, J. vd Meer, C.M.A. Bijleveld, C. M. A. Henkens, A.H. Cromme-Dijkhuis, V. J. J. Bom

Publikováno v: The Lancet. 336:1087-1090

Severe thromboembolism occurred in 3 of 37 patients who had undergone Fontan-type operations for correction of congenital heart defects several months to years after the operation. The patients were screened for coagulation factor abnormalities to fi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af2c9d6c9369fbce441a327d1c557b68
https://doi.org/10.1016/0140-6736(90)92568-3

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání